America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...
On a spring day this year, the New Jersey State Policemen’s Benevolent Association received three unusual visitors: ...
At the end of 2023, I had gained 37 pounds. So, my doctor and I decided to try Zepbound (tirzepatide), a weight loss ...
Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...
Weight loss typically begins right away and continues as the dosage ... Griffin, who didn't respond well to Wegovy, has ...
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs ...
GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback